Eurogentec and Novaptech combine their expertise We provide high-value services for the development and production of your nucleic acid-based aptamers.

Aptamers We collaborate with Novaptech, one of ANY TARGET – IN VARIOUS CONDITIONS the world leaders in the development of oligonucleotide aptamers....
They are considered as an alternative to antibodies. and even higher affinity and specificity compared to traditional monoclonal Novaptech identifies and